Hematuria risk workflow
Workflow for hematuria visits emphasizing bleeding severity, obstruction/infection risk, and rapid urology handoff.
Medium-risk workflowLast reviewed September 4, 2026
AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
Scope
- Use for
- Adult outpatient hematuria assessment; pregnancy and pediatric hematuria require separate pathways.
- Not for
- Hemodynamic instability, clot retention emergency, or severe sepsis presentations.
- Inpatient procedural and surgical urology management.
Immediate actions
- Determine visible versus microscopic blood, symptoms, menstrual contamination, recent instrumentation, trauma and infection context; document smoking and malignancy risk factors.
- Confirm a positive dipstick with urine microscopy. At least 3 RBC/hpf warrants risk assessment and an explicit investigation or follow-up plan; dipstick alone does not establish microscopic hematuria.
Red flags: escalate now
Treat these as urgent. Escalate early if concern persists or follow-up is unreliable.
- Emergency assessment for clot retention, inability to void, heavy bleeding with instability, or fever with suspected obstructed urinary tract.
- Acute kidney injury, severe pain or systemic illness requires urgent assessment.
First-line plan
- Check blood pressure, creatinine/eGFR and urine albumin-to-creatinine ratio; culture urine when infection is suspected. Consider nephrology as well as urology for proteinuria or renal dysfunction.
- Treat a confirmed transient cause and arrange repeat urine testing after resolution. Anticoagulant use does not remove the need to evaluate hematuria.
- Unexplained visible hematuria warrants prompt urology referral even after a single episode; do not wait for recurrence or completion of imaging to refer.
- Use the regional risk-based pathway for microscopic hematuria, imaging and cystoscopy. Kidney/bladder ultrasound is often the initial microscopic-hematuria study; visible hematuria may require CT urography after assessing renal function and contraindications.
Follow-up and monitoring
- Track urine results, imaging and referral completion; do not leave persistent unexplained hematuria without a plan.
- Re-evaluate new visible bleeding, urinary symptoms, increasing proteinuria or renal decline, including after a previously negative workup.
Linked resources
Tools and calculators
Referral checklists
Condition guidance
Before the patient leaves
Return precautions you can say as written:
“If symptoms get worse, new warning signs appear, or you cannot follow the plan from this visit, seek urgent care now.”
About this workflow
- Clinical owner
- Family Medicine Editorial Team
- Risk tier
- Medium
- Review cadence
- Every 6 months
- Last reviewed
- September 4, 2026AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
- Review status
- Evidence current. Next review due March 4, 2027.